Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Simple Search

Search Type: Criteria:

You could also try: inside layer (24), coating (68), liner (5)

Specialty Research Lead JD October 22

Description: Clinical Research Special Lead – Job Description Accountable to: LCRN Clinical Director Hours: A maximum of 1PA per week dependent on size
Url: /Media/Southampton-Clinical-Research/Downloads/Specialty-Research-Lead-JD-October-22.pdf

Specialty Research Lead JD Sept 2022.docx (2)

Description: Clinical Research Special Lead – Job Description Accountable to: LCRN Clinical Director Hours: A maximum of 1PA per week dependent on size
Url: /Media/Southampton-Clinical-Research/Downloads/Specialty-Research-Lead-JD-Sept-2022.docx-2.pdf

Carboplatin AUC6 4 cycles

Description: A document about Lung Cancer - Non-Small Cell (NSCLC).LUNG CANCER – NON-SMALL CELL (NSCLC)
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/Carboplatin-AUC-6-4-cycles.pdf

Pemigatinib

Description: Chemotherapy Protocol CHOLANGIOCARCINOMA PEMIGATINIB Regimen  Cholangiocarcinoma - Pemigatinib Indication Pemigatinib for locally advanced or metastatic cholangiocarcinoma which has a fibroblast growth factor
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Hepatobiliary/Pemigatinib.pdf

Adult safeguarding - patient information

Description: Information about safeguarding adults. Every adult has the right to be safe and feel safe. If you, or someone you know
Url: /Media/UHS-website-2019/Patientinformation/Other/Adult-safeguarding-2688-PIL.pdf

Specialty Research Lead JD August 2022

Description: Clinical Research Special Lead – Job Description Accountable to: LCRN Clinical Director Hours: A maximum of 1PA per week dependent on size
Url: /Media/Southampton-Clinical-Research/Downloads/Specialty-Research-Lead-JD-August-2022.pdf

Cyclophosphamide and Etoposide

Description: Chemotherapy Protocol LUNG CANCER – SMALL CELL (SCLC) CYCLOPHOSPHAMIDE and ETOPOSIDE Regimen SCLC - Cyclophosphamide and Etoposide Indication First or second line therapy
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-small-cellSCLC/CyclophosphamideandEtoposide.pdf

Cyclophosphamide, Doxorubicin, Vincristine

Description: Regimen Chemotherapy Protocol LUNG CANCER – SMALL CELL (SCLC) CYCLOPHOSPHAMIDE-DOXORUBICIN-VINCRISTINE SCLC – Cyclophosphamide-Doxorubicin-Vincristine Indication Second line treatment of SCLC
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-small-cellSCLC/CyclophosphamideDoxorubicinVincristine.pdf

Carboplatin

Description: Chemotherapy Protocol LUNG CANCER – SMALL CELL (SCLC) CARBOPLATIN (AUC6) 6 CYCLES Regimen  SCLC - Carboplatin (AUC6) 6 Cycles Indication  Second line treatment
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-small-cellSCLC/Carboplatin.pdf

Colorectal multidisciplinary team - patient information

Description: Following your diagnosis of bowel (colorectal) cancer, you will be cared for by a team of medical experts and health professionals
Url: /Media/UHS-website-2019/Patientinformation/Cancercare/Colorectal-multidisciplinary-team-1152-PIL.pdf

531 to 540 of 743

Previous … 52 53 54 55 56 … Next